Intravenous Iron Therapy to Treat Anemia in Oncology: A Mapping Review of Randomized Controlled Trials
Jayne Lim(The University of Western Australia), Toby Richards(University College London), Beth MacLean(The University of Western Australia), Annas Al‐Sharea(Baker Heart and Diabetes Institute), Michael Auerbach(Georgetown University)
Cited by 10
Related Papers
Restenosis and risk of stroke after stenting or endarterectomy for symptomatic carotid stenosis in the International Carotid Stenting Study (ICSS): secondary analysis of a randomised trial
|The Lancet Neurology|2018|178
Recommendations From the International Consensus Conference on Anemia Management in Surgical Patients (ICCAMS)
|Annals of Surgery|2022|164
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
|Kidney International|2023|121
Systematic review and consensus definitions for the Standardized Endpoints in Perioperative Medicine (StEP) initiative: cardiovascular outcomes
|British Journal of Anaesthesia|2020|111
The misogyny of iron deficiency
|Anaesthesia|2021|74